美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

First Trust SMID Growth Strength ETF

29.87

-0.0066-0.02%

成交量：2,011.00

成交额：6.01万

市值：2,987.01万

市盈率：- -

高：29.87

开：29.87

低：29.87

收：29.88

数据加载中...

总览公司新闻公告

概念

no data

没有相关数据

资金流向

资金流入：

资金流出：

新闻

Travere Therapeutics的FILSPARI®补充新药申请获FDA受理，用于FSGS治疗Travere Therapeutics FILSPARI® sNDA Accepted by FDA for FSGS Treatment

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/FSGS"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"FSGS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FSGS\",,,,,undefined,":{"symbol":"FSGS","market":"US","secType":"STK","nameCN":"First Trust SMID Growth Strength ETF","latestPrice":29.87,"timestamp":1751473506822,"preClose":29.8766,"halted":0,"volume":2011,"delay":0,"floatShares":1000002,"shares":1000002,"eps":0,"marketStatus":"交易中","change":-0.0066,"latestTime":"07-02 12:27:55 EDT","open":29.87,"high":29.87,"low":29.87,"amount":60064.421307000004,"amplitude":0,"askPrice":29.88,"askSize":300,"bidPrice":29.79,"bidSize":500,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1751486400000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":29.8766,"sharesOutstanding":1000002,"nav":29.65,"aum":29650059.3,"dividendRate":0.025444,"bidAskSpread":0,"volumeRatio":3.376857},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FSGS\",,,,,undefined,":{"symbol":"FSGS","floatShares":1000002,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":3.376857,"shares":1000002,"dividePrice":0.76,"high":29.87,"amplitude":0,"preClose":29.8766,"low":29.87,"week52Low":24.39,"pbRate":"--","week52High":32.96,"institutionHeld":0,"latestPrice":29.87,"committee":0.25,"eps":0,"divideRate":0.025444,"volume":2011,"delay":0,"ttmEps":0,"open":29.87,"prevYearClose":29.7151,"prevWeekClose":29.5725,"prevMonthClose":29.658,"prevQuarterClose":29.658,"fiveDayClose":29.05,"twentyDayClose":29.4064,"sixtyDayClose":25.2975},"@#url:\"https://hq.skytigris.cn/market/plate/belongs/FSGS\",params:#limit:6,delay:false,,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"FSGS\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2535739550","title":"Travere Therapeutics的FILSPARI®补充新药申请获FDA受理，用于FSGS治疗Travere Therapeutics FILSPARI® sNDA Accepted by FDA for FSGS Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2535739550","media":"动脉网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535739550?lang=zh_cn&edition=fundamental","pubTime":"2025-05-16 18:48","pubTimestamp":1747392480,"startTime":"0","endTime":"0","summary":"FSGS is a rare kidney disorder that often leads to kidney failure. It affects both children and adults and is marked by protein leakage into the urine due to damage to the kidney's filtering units. This leakage can lead to further kidney damage. It is estimated that over 40,000 people in the United States are affected by FSGS, with similar numbers in Europe.FSGS是一种罕见的肾脏疾病，常导致肾衰竭。FILSPARI 的安全性与厄贝沙坦相当，未报告新的安全隐患。Travere’s progress with FILSPARI represents a potential new option for people living with FSGS, a condition for which there are currently no approved targeted therapies.Travere公司在FILSPARI方面的进展代表了对于患有FSGS的人们的一个潜在新选择，目前该病症尚无获批的针对性疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516184914975bb363&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516184914975bb363&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TVTX","BK4007","BK4539","FSGS","LENZ"],"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":1,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FSGS\",params:#limit:5,,,undefined,":[{"date":"2024-12-13","symbol":"FSGS","amount":0.3931,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-13","defaultRemindTime":1734100200000,"name":"FIRST TRUST EXCHANGE-TRADED FUND VI FIRST TRUST SMID GROWTH STRENGTH ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-31","payableDate":"2024-12-13","currency":"USD","dateTimestamp":1734066000000,"payDate":"2024-12-31"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FSGS\",market:\"US\",,,undefined,":[{"executeDate":"2024-12-13","recordDate":"2024-12-13","paymentDate":"2024-12-31","value":0.3931,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"FSGS\",market:\"US\",delay:false,,,undefined,":{}}}